| Authors: |
Infante V; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Cintra MACT; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Fernandes EG; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Loch AP; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Ragiotto L; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Braga PE; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Salomão MDG; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Lucchesi MBB; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., de Oliveira MMM; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Gattás VL; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., da Silva AS; Centro de Saúde Escola da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP-USP) Dr. Joel Domingos Machado, São Paulo, Brazil., Boas PJFV; Centro de Saúde Escola da Faculdade de Medicina de Botucatu-Unesp, São Paulo, Brazil., Lopes MH; Centro de Referência de Imunobiológicos Especiais Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (CRIE-HCFMUSP), São Paulo, Brazil., Moreira J; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil., Boulos FC; Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil. |